The FDA's proposed rule for foreign tobacco factories landed in the Federal Register on June 29, 2026. The comment window closes September 14. Premium cigars are exempt, and the whole exemption runs one footnote long.

That footnote is the story. The rule would make foreign manufacturers register their factories with the agency, list every tobacco product they ship into the United States, and open their doors to FDA inspectors. Handmade premium cigars sit outside it. But the reason they sit outside has almost nothing to do with cigars, and the ledge is narrower than the trade will want to admit.

What follows is a close read of the carve-out: how the rule works, what the premium cigar exemption actually rests on, and the spots on a real factory floor where "premium cigars are exempt" quietly stops being true.

What the rule asks foreign factories to do

On paper it's mundane: the title reads "Establishment Registration and Product Listing for Tobacco Products," filed under Docket No. FDA-2025-N-7130, and it would build a new 21 CFR Part 1108. The logic is old. Domestic manufacturers already register their plants and list their products with the FDA. Foreign manufacturers don't. This closes the gap.

Under the proposal, the owner of a foreign establishment that makes, prepares, or processes a tobacco product would register that establishment, refresh the registration once a year, and file a product listing that gets updated twice a year. Every listing has to carry an FDA-assigned Submission Tracking Number, the product's nicotine concentration and source, any characterizing flavor, package sizes, and dimensions. For vapes it goes deeper, down to e-liquid volume and battery capacity. The rule would also require manufacturers to hold on to their labeling and advertising records for at least four years, so the agency can check after the fact whether a product was marketed the way it was listed.

Authority for it comes from section 905 of the Food, Drug, and Cosmetic Act, added by the Tobacco Control Act of 2009. Section 905(h) is the piece written for foreign plants, and it directs the Secretary of Health and Human Services to issue regulations before any of it binds. This rule is that step. And once a foreign establishment is on the register, sections 905(g) and 905(h) make it open to FDA inspection. The same information feeds the agency's annual export report to Congress and, more to the point, its power to refuse a shipment at the border when the paperwork doesn't match.

The reach runs past the factory to whoever brings the cigars in. A foreign manufacturer that won't or can't register makes its products harder to clear at the port, because the agency can treat an unlisted product as grounds to refuse admission. In practice that pushes the burden onto the U.S. importer of record, who needs the overseas supplier on the register to keep shipments moving. For a compliant maker the lift is mostly clerical: a registration on file, a listing kept current, an inspection to accommodate now and then. For a maker that would rather stay invisible, the point of the rule is that invisibility gets more expensive.

Read the agency's own framing and the target is obvious, and it isn't cigars. The FDA's June 26 announcement leads with vapes: illegal disposable e-cigarettes, most made overseas, many built to appeal to teenagers. "All companies selling tobacco products in the United States should play by the same rules," said Bret Koplow, acting director of the FDA's Center for Tobacco Products, in the release. He describes inspecting foreign factories to "stop illegal products before they reach American consumers." He names no cigar, not once.

The carve-out lives in footnote 4

Cigars show up a single time in the proposal, in a footnote. It's worth quoting whole, because it is the entire legal foundation for the exemption:

The proposed rule would thus not apply to "premium cigars" that are not subject to chapter IX of the FD&C Act. By rulemaking, FDA has deemed all cigars, among other products, subject to chapter IX of the FD&C Act. On August 9, 2023, the U.S. District Court for the District of Columbia issued an order vacating that rule (generally referred to as the Deeming Rule) "insofar as it applies to premium cigars."... On January 24, 2025, the U.S. Court of Appeals for the District of Columbia Circuit affirmed the district court's order, in part, and reversed and remanded the case back to the district court "so that the district court can invite briefing on the appropriate definition of premium cigars."

So the exemption is not a favor from the FDA. It's the residue of a lawsuit the industry has fought since 2016, when the Cigar Association of America, Cigar Rights of America, and the Premium Cigar Association sued over the original Deeming Rule. Premium cigars sit outside this new rule only because a court pulled them outside the FDA's reach first. I traced what that vacatur actually changed when the district court finalized it, and the short version is that the agency lost its authority over the category, not that it chose to let go.

Strip the vacatur away and the footnote collapses. If premium cigars were still deemed products under chapter IX, they'd be swept into Part 1108 with everything else, and a factory in the Dominican Republic rolling nothing but handmade coronas would be registering and opening its doors like any vape plant in Shenzhen. The court is doing the work here. The FDA is only acknowledging it.

Why the FDA lost the cigars in the first place

The exemption traces back to a finding that the FDA ignored its own evidence. When the agency deemed all cigars in 2016, it treated a hand-rolled Nicaraguan toro and a gas-station cigarillo as the same public-health problem. The plaintiffs said that was arbitrary, and the courts agreed.

Two pieces of evidence did most of the damage. One was a 2014 study by Catherine Corey and colleagues in the CDC's Morbidity and Mortality Weekly Report, which looked at the 2012-2013 National Adult Tobacco Survey of 60,192 adults and found that among premium cigar smokers, 71.2 percent reported using them rarely. The other was the National Cancer Institute's 1998 Monograph No. 9, which, as the district court put it, found no statistically significant difference in all-cause mortality at the low, infrequent end of cigar use. The FDA had this material and, the courts found, waved it away.

The case took most of a decade to reach this point, and the FDA didn't lose it all at once. In a 2018 ruling the district court upheld most of the Deeming Rule, cigars included. The turn came later. On July 5, 2022, the court found the agency's decision to sweep premium cigars in with the rest arbitrary and capricious, and on August 9, 2023, it vacated the rule for that category outright. Each step sits in the record under the same case number, 1:16-cv-01460. So the exemption isn't one dramatic ruling; it's the slow accretion of an agency losing an argument it kept making.

That history is why the D.C. Circuit's language matters. Writing for the panel in January 2025, Senior Circuit Judge A. Raymond Randolph affirmed Judge Amit Mehta's vacatur and closed by saying the appeals court would "otherwise affirm the district court's well-reasoned opinion in full." A federal appeals court calling the ruling that stripped premium cigars out of FDA authority "well-reasoned" is the ground the footnote stands on. Yet the same opinion left one hole, and it is the hole the whole exemption now hangs over.

"Premium" is still an open definition

The seam runs through the word "premium." The D.C. Circuit affirmed the vacatur, but it handed one question back to the district court: what a premium cigar actually is.

A premium cigar, by the definition the court took from the FDA's own 2016 rulemaking, is wrapped in whole tobacco leaf, bound with a leaf binder, filled primarily with long filler, rolled by hand, sold with no filter or tip, carries no characterizing flavor other than tobacco, and weighs more than six pounds per thousand. Miss one of those and you aren't premium for the FDA's purposes; you're a deemed product like any machine-made cigarillo.

So which cigars actually count as premium? As of the summer of 2026, that is still an open question. The Cigar Association of America argued on remand for a broader line, one that critics warned could let flavored cigars slip into the same exemption, and the appeals court sent the definition back for briefing rather than settling it from the bench. That distinction is not academic. The moment the definition narrows, some sticks that feel exempt today land back inside the FDA's authority, and inside a rule like this one.

The stakes behind that open question are concrete. A cigar that falls back under chapter IX doesn't merely fill out a form. It enters the FDA's premarket authorization pathway, owes the user fees the agency collects on regulated tobacco, and carries the warning labels the industry spent years fighting. The appeals court was careful to say its ruling wouldn't reopen past user fee payments, which tells you how much money rode on the category's status. For a boutique house with a dozen SKUs, being called a deemed product instead of a premium one is the gap between a cottage operation and a compliance department.

What the exemption does not cover

Here's the part the headline misses. "Premium cigars are exempt" is a statement about products. This rule regulates establishments. Those aren't the same thing.

Most large cigar factories don't make one kind of cigar. A Nicaraguan operation in Esteli might roll a handmade premium line in the morning and run machine-bunched or flavored production in the afternoon. The premium sticks are outside chapter IX. The flavored and machine-made ones are not. So the establishment still has a listing obligation for the deemed products it makes, and once it's registered for those, sections 905(g) and 905(h) put the whole facility within reach of an FDA inspector.

That's the quiet reach of the rule. A factory can be exempt for its premium output and still be a registered, inspectable establishment because of everything else it rolls. The cigars you'd call premium ride along inside a building the agency can now walk into. Think of the big Dominican houses behind Arturo Fuente, or the Esteli campuses that turn out My Father; a plant that makes only uninfused, handmade, long-filler cigars has a real argument that it stays off the register, but a plant with a flavored SKU or a machine line does not.

The importer sits in the same bind. Whoever is the U.S. importer of record for a foreign plant's flavored or machine-made cigars has a stake in that plant being registered, which drags the establishment's paperwork toward compliance even when its marquee product is a handmade, exempt corona. A Tabacalera that built its name on premium output can find its registration driven by the least premium thing it ships. That's the practical outcome the footnote doesn't describe, and it's the one a factory manager feels first.

None of this is settled by the rule. It's settled product by product, factory by factory, against a definition of premium that is itself still moving. Not every foreign cigar factory is exempt, and the ones that are exempt for their premium cigars aren't necessarily exempt as establishments. That distinction is where the comfort of the footnote runs out.

The FDA's own price tag

Cost is the other place the rule shows its hand. According to the regulatory-impact analysis filed with the proposal, 20-year annualized costs land between $6.80 million and $26.55 million, with a primary estimate of $15.57 million.

The split is the part worth reading twice. Foreign establishments would carry about $0.37 million of that, by the FDA's own reckoning, or roughly 2.4 percent. The agency itself absorbs the other 97.5 percent, most of it the cost of sending inspectors abroad. Domestic firms barely register on the ledger. Whatever this rule is, it is not an expensive burden on foreign manufacturers by the government's own math (those are the agency's figures, not an outside estimate).

Which is why I read the burden claims skeptically and read the inspection access as the real point. The dollars are small; the doors are what's new. The premium-cigar industry's lobbying spend on FDA exemptions is the single most under-reported story of the last decade, and a rule that costs foreign makers almost nothing while handing the agency a key to their factories is exactly the sort of thing that spend exists to shape. If a company won't respond, the article says so, by name; on this one, the trade groups have been public about watching the docket, and their comment letters, if they come, will land before September 14.

I've learned to be careful with numbers on this beat. In late 2024, I ran a story about a Padron reformulation built on a single anonymous source, and it was wrong; the tipster turned out to be a competitor planting a smear, and I pulled the piece within hours. The lesson stuck. A figure without a primary source behind it is a rumor wearing a suit, whether it comes from a tipster or from an "industry sources estimate" line in a press release.

So what's actually unresolved as the comment period runs? Three things. Whether the district court's forthcoming definition of premium holds the current line or narrows it. Whether the trade groups file, and what they ask for. And whether a rule written to catch Chinese disposable vapes ends up, through the establishment-registration back door, giving the FDA more visibility into Nicaraguan and Dominican cigar factories than the premium exemption suggests on its face.

The footnote says premium cigars are safe. The footnote is also one sentence in a rule about something else entirely, resting on a definition a court hasn't finished writing. That's not the same as safe. For now, it's only quiet.

Disclosure: When we link to a specific product, we link to a retailer our writers think charges a fair price for it. The makers named here roll for the U.S. market through houses whose catalogs are easy to browse if you want to see what actually clears customs, from Drew Estate's Nicaraguan lines to the Tampa-made cigars of J.C. Newman, the last big cigar factory still running on U.S. soil.

Sources & Notes